September 2018 Vol 11, No 6

Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia

Craig White, PhD; Winghan Jacqueline Kwong, PharmD, PhD; Hilary Armstrong, PhD; Michael Behling; Jeffrey Niemira; Kathy Lang, PhD

Stakeholder Perspective

Real-World Drug Prescribing and Utilization Studies Can Inform Optimized Patient Care and Insurance Coverage

F. Randy Vogenberg, PhD, RPh

Editorial

"The Dirty Dozen"

David B. Nash, MD, MBA

Original Research, Regulatory

Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015

Xiaomeng Yue, BPharm, MS; Jeff Jianfei Guo, BPharm, MS, PhD; Patricia R. Wigle, PharmD

Stakeholder Perspective

The Importance and Benefits of Smoking-Cessation Therapy

Jack E. Fincham, PhD, RPh

Business, Original Research

Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies

Vincent J. Willey, PharmD; Sheldon Kong, PhD; Bingcao Wu, MS; Amit Raval, PhD; Todd Hobbs, MD; Andrea Windsheimer, PharmD; Gaurav Deshpande, MS, PhD; Ozgur Tunceli, PhD; Brian Sakurada, PharmD; Jonathan R. Bouchard, MS, RPh

Results 1 - 4 of 4